Research graph
References from Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.abl4784
10.1126/science.abl4784 · 2021 · External reference
10.1021/acs.jmedchem.2c00117
10.1021/acs.jmedchem.2c00117 · 2022 · External reference
Unresolved reference
External reference
10.1038/s41467-024-50931-8
10.1038/s41467-024-50931-8 · 2024 · External reference
10.1021/acs.jmedchem.5c00754
10.1021/acs.jmedchem.5c00754 · 2025 · External reference
10.1021/acs.jmedchem.4c01342
10.1021/acs.jmedchem.4c01342 · 2024 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
2022 · External reference
10.1056/nejmoa2116846
10.1056/nejmoa2116846 · 2022 · External reference
10.1128/spectrum.00077-23
10.1128/spectrum.00077-23 · 2023 · External reference
10.4269/ajtmh.24-0696
10.4269/ajtmh.24-0696 · 2025 · External reference
Unresolved reference
External reference
10.1038/s41591-022-01780-9
10.1038/s41591-022-01780-9 · 2022 · External reference
10.1002/cpt.3267
10.1002/cpt.3267 · 2024 · External reference
10.1093/ofid/ofae233
10.1093/ofid/ofae233 · 2024 · External reference
10.1038/s41586-022-05514-2
10.1038/s41586-022-05514-2 · 2023 · External reference
10.1126/sciadv.add7197
10.1126/sciadv.add7197 · 2022 · External reference
10.1126/sciadv.adl4013
10.1126/sciadv.adl4013 · 2024 · External reference
10.1128/spectrum.02980-23
10.1128/spectrum.02980-23 · 2024 · External reference
10.1016/s1473-3099(25)00238-5
10.1016/s1473-3099(25)00238-5 · 2025 · External reference
10.2217/fvl-2023-0115
10.2217/fvl-2023-0115 · 2023 · External reference
10.1038/s41586-021-03673-2
10.1038/s41586-021-03673-2 · 2021 · External reference
10.1371/journal.pbio.3001284
10.1371/journal.pbio.3001284 · 2021 · External reference
10.1038/s41467-020-17892-0
10.1038/s41467-020-17892-0 · 2020 · External reference
10.1038/s41586-021-04245-0
10.1038/s41586-021-04245-0 · 2022 · External reference
10.1021/acs.jcim.8b00744
10.1021/acs.jcim.8b00744 · 2019 · External reference
10.1016/j.ijpharm.2004.10.007
10.1016/j.ijpharm.2004.10.007 · 2005 · External reference
10.1023/a:1020765025857
10.1023/a:1020765025857 · 2002 · External reference
10.1016/s0090-9556(24)14938-0
10.1016/s0090-9556(24)14938-0 · 1999 · External reference
10.1016/j.ejps.2022.106155
10.1016/j.ejps.2022.106155 · 2022 · External reference
10.1111/cts.13126
10.1111/cts.13126 · 2022 · External reference
10.1089/adt.2010.0333
10.1089/adt.2010.0333 · 2010 · External reference
10.1002/1098-2280(2000)36:1<72::aid-em10>3.0.co;2-y
10.1002/1098-2280(2000)36:1<72::aid-em10>3.0.co;2-y · 2000 · External reference
10.1016/j.mrrev.2012.12.002
10.1016/j.mrrev.2012.12.002 · 2013 · External reference
10.1787/9789264071162-en
10.1787/9789264071162-en · External reference
10.1517/17425255.2.6.823
10.1517/17425255.2.6.823 · 2006 · External reference
10.1038/nrd3845
10.1038/nrd3845 · 2012 · External reference
